Skip to main content

Kazuhiro Iwaï

Kyoto University · Biochemistry, Genetics and Molecular Biology

About the Lab

Professor Kazuhiro Iwaï's research lab focuses on the molecular mechanisms underlying cellular signaling, protein degradation, and post-translational modifications, particularly ubiquitination and its role in disease pathogenesis. The lab investigates the regulation of key tumor suppressors like pVHL and iron regulatory protein 2 (IRP2), exploring how oxidative stress and iron homeostasis intersect with ubiquitin ligase systems. A central theme is the identification and functional characterization of E3 ubiquitin ligases, such as the VBC-CUL-2 and LUBAC complexes, in controlling NF-κB signaling, apoptosis, and cancer progression. The lab also examines adhesion molecules and cell surface receptors in tumor-endothelial interactions, contributing to understanding metastasis and inflammation.

ubiquitinationprotein degradationNF-κB signalingiron homeostasistumor suppressor

Research Overview

Papers
8
Total Citations
158
Papers (5y)
62
Primary Field
Biochemistry, Genetics and Molecular Biology

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
62total
2020
2021
2022
2023
2024
Citations per year (5y)
666total
20202021202220232024

Selected Papers

11
1
Article|606 citations·2011
SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex
Fuminori Tokunaga, Tomoko Nakagawa, Masaki Nakahara, Yasushi Saeki, Masami Taniguchi, Shin‐ichi Sakata, Keiji Tanaka, Hiroyasu Nakano, Kazuhiro Iwaï
SJR Q1FWCI 20.1Nature
Cancer ResearchBiochemistry, Genetics and Molecular Biology
2
letter|503 citations·1999
Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
Kazuhiro Iwaï, Koji Yamanaka, Takumi Kamura, Nagahiro Minato, Ronald Conaway, Joan Conaway, Richard D. Klausner, Arnim Pause
SJR Q1FWCI 13.3Proceedings of the National Academy of SciencesOA

Mutations of von Hippel-Lindau disease (VHL) tumor-suppressor gene product (pVHL) are found in patients with dominant inherited VHL syndrome and in the vast majority of sporadic clear cell renal carcinomas. The function of the pVHL protein has not been clarified. pVHL has been shown to form a complex with elongin B and elongin C (VBC) and with cullin (CUL)-2. In light of the structural analogy of VBC-CUL-2 to SKP1-CUL-1-F-box ubiquitin ligases, the ubiquitin ligase activity of VBC-CUL-2 was exam

Cancer ResearchBiochemistry, Genetics and Molecular Biology
3
Article|314 citations·1994
Differential expression of bcl-2 and susceptibility to anti-Fas- mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils
Kazuhiro Iwaï, Takeshi Miyawaki, T Takizawa, A Konno, Kunio Ohta, A Yachie, Hiroaki Seki, Naoyuki Taniguchi
SJR Q1FWCI 10.6BloodOA

The recently identified Fas antigen (Ag) is a cell surface molecule that can mediate apoptosis. The cytoplasmic product of proto-oncogene bcl-2 has been shown to prolong the cellular survival by inhibiting apoptosis. To elucidate the physiologic significance of expression of both molecules, we examined the expression of Fas Ag and bcl-2 on blood leukocyte populations and evaluated their sensitivity to the cytolytic action of anti-Fas antibody. Although Fas Ag was expressed on a fraction of lymph

Molecular BiologyBiochemistry, Genetics and Molecular Biology
4
Article|296 citations·1998
Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: Implications for degradation of oxidized proteins
Kazuhiro Iwaï, Steven K. Drake, Nancy B. Wehr, Allan M. Weissman, Timothy LaVaute, Nagahiro Minato, Richard D. Klausner, Rodney L. Levine, Tracey A. Rouault
SJR Q1FWCI 9.0Proceedings of the National Academy of SciencesOA

The ability of iron to catalyze formation of reactive oxygen species significantly contributes to its toxicity in cells and animals. Iron uptake and distribution is regulated tightly in mammalian cells, in part by iron regulatory protein 2 (IRP2), a protein that is degraded efficiently by the proteasome in iron-replete cells. Here, we demonstrate that IRP2 is oxidized and ubiquitinated in cells before degradation. Moreover, iron-dependent oxidation converts IRP2 into a substrate for ubiquitinati

Cell BiologyBiochemistry, Genetics and Molecular Biology
5
Review|218 citations·2014
Linear ubiquitin chains: NF-κB signalling, cell death and beyond
Kazuhiro Iwaï, Hiroaki Fujita, Yoshiteru Sasaki
SJR Q1FWCI 9.0Nature Reviews Molecular Cell Biology
Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article|212 citations·1995
Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2.
Kazuhiro Iwaï, Richard D. Klausner, Tracey A. Rouault
SJR Q1FWCI 5.0The EMBO JournalOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Review|210 citations·2009
Linear polyubiquitination: a new regulator of NF‐κB activation
Kazuhiro Iwaï, Fuminori Tokunaga
SJR Q1FWCI 12.2EMBO ReportsOA
Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Review|175 citations·2012
Diverse ubiquitin signaling in NF-κB activation
Kazuhiro Iwaï
SJR Q1FWCI 9.0Trends in Cell Biology
Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|149 citations·2005
Involvement of Heme Regulatory Motif in Heme-Mediated Ubiquitination and Degradation of IRP2
Haruto Ishikawa, Michiko Kato, Hiroshi Hori, Koichiro Ishimori, Takayoshi Kirisako, Fuminori Tokunaga, Kazuhiro Iwaï
SJR Q1FWCI 5.4Molecular Cell
Molecular BiologyBiochemistry, Genetics and Molecular Biology
10
Article|119 citations·1993
Importance of E‐selectin (ELAM‐1) and sialyl lewis<sup>a</sup> in the adhesion of pancreatic carcinoma cells to acttvated endothelium
Kazuhiro Iwaï, Hiroshi Ishikura, Mitsuhito Kaji, Hiroshi Sugiura, Akihiro Ishizu, Chisa Takahashi, Hiroyuki Kato, Tatsuzo Tanabe, Takashi Yoshtki
SJR Q1FWCI 1.5International Journal of Cancer

Adhesion molecules involved in attachment between human pancreatic carcinoma and activated endothelial cells in vitro were investigated. Basal adhesion occurred between 6 pancreatic carcinoma cell lines and unstimulated human umbilical vein endothelial cells (HUVEC), and augmented basal adhesion to activated HUVEC was only seen when pancreatic cancer cells expressed sialyl Lewisa (SLea) and sialyl Lewisx (SLex). Activation of HUVEC with interleukin 1-beta (IL-1 beta) or tumor necrosis factor-alp

Immunology and AllergyMedicine
11
Review|115 citations·2015
Roles of linear ubiquitinylation, a crucial regulator of <scp>NF</scp>‐κB and cell death, in the immune system
Katsuhiro Sasaki, Kazuhiro Iwaï
SJR Q1FWCI 6.9Immunological Reviews

Linear ubiquitinylation, a newly identified post-translational modification, is catalyzed by the linear ubiquitin assembly complex (LUBAC), which is composed of three different subunits, HOIL-1L (heme-oxidized IRP2 ligase 1L), HOIP (HOIL-1 interacting protein), and SHARPIN (SHANK-associated RH domain-interacting protein). LUBAC plays a critical role in the activation of nuclear factor-κB (NF-κB) signaling triggered by a variety of stimuli, including tumor necrosis factor-α (TNF-α), interleukin-1

Molecular BiologyBiochemistry, Genetics and Molecular Biology

Research Areas

Molecular BiologyImmunologyPathology and Forensic MedicineCell BiologyOncologyAerospace Engineering

Explore this research further with Nubint

Open papers in the app to read, cite, and organize with AI.